To model this aspect of ALS/FTD, HARDEN was applied to previously characterized patient derived iPSCs (7) harboring the repeat expansion but with limited C9orf72 promoter methylation (Supplemental Figure S7). Here, C9orf72 is linked to amyotrophic lateral sclerosis.